Antiasthmatic Agents

Abstract

The article contains sections titled: 1. Introduction 2. Bronchodilators (Relievers) 2.1. Adrenoceptor Agonists 2.1.1. Aminocatechol Derivatives 2.1.2. Resorcinol Derivatives 2.1.3. Saligenin Derivatives 2.1.4. Further Arylalkylamines 2.2. Xanthine Derivatives 2.3. Anticholinergic Drugs 3. Anti‐Inflammatory Drugs or Controllers 3.1. Glucocorticosteroids 3.2. Antileukotrienes 3.3. Cromolyns 3.4. Anti‐IgE Antibodies 3.5. Allergen‐Specific Immunotherapy 4. Fixed Dose Combination Therapies 4.1. Fixed Dose Combinations of Adrenoceptor Agonists and Glucocorticosteroids 4.2. Fixed Dose Combinations of Adrenoceptor Agonists and Anticholinergic Drugs 4.3. Fixed Dose Combinations of Adrenoceptor Agonists and Cromolyns 4.4. Fixed Dose Combinations of Xanthines 5. Newer Concepts in Asthma Therapy

Rapid uptake of pharmaceutical salbutamol from aqueous solutions with anionic cellulose nanofibrils: The importance of pH and colloidal stability in the interaction with ionizable pollutants

“…One example is salbutamol (4-[2-(tert-butylamino)-1hydroxyethyl]-2-(hydroxymethyl)phenol, CAS 18559-94-9) (Figure 1), an amphoteric compound that can be present as four different species in aquatic solutions, depending on the pH [4]. Being a β2-adrenoceptor agonist with short-acting bronchodilation and antiinflammatory effects, it is extensively used in the treatment of asthma [5]. Taking into consideration its widespread use, potential harmful effects [6], and inconsistent removal efficiency in conventional wastewater treatment [6][7][8][9][10][11], more information is needed regarding the behavior of salbutamol in water and its removal mechanisms under different conditions.…”